Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Randox announces CE Marking of its Sexually Transmitted Infection (STI) Multiplex Array

Published: Wednesday, November 28, 2012
Last Updated: Wednesday, November 28, 2012
Bookmark and Share
Randox is pleased to announce the CE marking of the STI Multiplex Array, recognising its use as a powerful diagnostic weapon in the battle to control sexually transmitted infections.

Sexually transmitted infections (STIs) are on the increase worldwide and present a major challenge to world public health.  This rise in STI cases shows that current measures, including existing technologies and screening programmes cannot cope with clinical need. STIs are of significant medical, social and economic importance affecting up to 25-30% of young adults, with the developing world having a disproportionate burden of disease. STIs can be difficult to diagnose because of atypical or asymptomatic presentation and left untreated can result in serious health problems including infertility or complications during pregnancy.  Those with untreated STIs can also act as reservoirs for future infection.

To avoid preventable health complications and to encourage more responsible sexual health practices, Randox has developed the STI Multiplex Array that can simultaneously detect 10 of the most prevalent STIs from a single urine or swab sample, in a single test within 5 hours. These STIs include Chlamydia trachomatis, Neisseria gonorrhoea, Trichomonas vaginalis, Treponema pallidum (syphilis), Herpes simplex 1 & 2, Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Haemophilus ducreyi.

STI-Multiplex-Array.gif


In addition to providing the most comprehensive STI screen available, testing for multiple STI pathogens can identify secondary infections, which are present in greater numbers than previously thought, and allow specific treatments for all infections diagnosed.  The accuracy and comprehensive diagnostic ability of the Randox STI Multiplex Array compensates for many of the current diagnosing limitations and has the potential to revolutionise STI diagnosis. This will improve patient outcome and reduce the social and economical burden of such pathogens. Using this test has added benefits through more appropriate use of antibiotics, which will reduce the potential for antibiotic resistance.

The CE marking of the STI Multiplex Array signifies that this groundbreaking test is suitable for the accurate diagnosis of STIs in a clinical setting and provides further evidence that Randox continues to develop innovative diagnostic solutions to meet the increasing demands of healthcare providers worldwide.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
DNA Barcodes Gone Wild
A team of researchers at University of Toronto’s Donnelly Centre and Sinai Health System’s Lunenfeld-Tanenbaum Research Institute (LTRI) has developed a new technology that can stitch together DNA barcodes inside a cell to simultaneously search amongst millions of protein pairs for protein interactions.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Grant to Fund Million Peaks Project
The European Research Council (ERC) has awarded a prestigious Advanced Grant to Prof. Peter Schoenmakers, Prof. Albert Polman and Prof. Huib Bakker, all three of whom work at the University of Amsterdam (UvA).
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!